Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from Regeneus Ltd. ( (AU:CMB) ).
Cambium Bio Limited, a company listed on the ASX under the ticker CMB, addressed queries regarding the late lodgement of certain appendices related to changes in directorship. The company attributed the delay to an administrative oversight and assured that its current compliance arrangements with the ASX Listing Rules are adequate and enforced. Cambium Bio emphasized that the late lodgement was an isolated incident and unlikely to recur.
More about Regeneus Ltd.
YTD Price Performance: -2.50%
Average Trading Volume: 22,662
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$5.52M
For detailed information about CMB stock, go to TipRanks’ Stock Analysis page.